Filing Details
- Accession Number:
- 0001724521-25-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-03 16:08:03
- Reporting Period:
- 2024-12-31
- Accepted Time:
- 2025-01-03 16:08:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1724521 | Arcus Biosciences Inc. | RCUS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1653881 | C. Robert Ii Goeltz | C/O Arcus Biosciences, Inc. 3928 Point Eden Way Hayward CA 94545 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-12-31 | 3,594 | $15.00 | 60,138 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2023.
Billionaire Hedge Funds
